Myrtle Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 0.90 M
- Revenue Growth 106.45%
- Profit Growth 122.54%
- Ebitda -9748.39%
- Net Worth 11.35%
- Total Assets -30.72%
About Myrtle Pharmaceutical
Myrtle Pharmaceutical Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 September 2018 (Six years and four months 25 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.90 M.
Vijai Asthana, Ranvijay Singh, and Neeraj Shukla serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85320DL2018PTC339853
- Company No.
339853
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Myrtle Pharmaceutical Private Limited offer?
Myrtle Pharmaceutical Private Limited offers a wide range of products and services, including Common Disease Medicines, Steroid.
Who are the key members and board of directors at Myrtle Pharmaceutical?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijai Asthana  | Director | 30-Sep-2018 | Current |
| Ranvijay Singh | Director | 30-Sep-2018 | Current |
| Neeraj Shukla | Director | 30-Sep-2018 | Current |
Financial Performance of Myrtle Pharmaceutical.
Myrtle Pharmaceutical Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 106.45% increase. The company also saw a substantial improvement in profitability, with a 122.54% increase in profit. The company's net worth Soared by an impressive increase of 11.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Myrtle Pharmaceutical?
Unlock access to Myrtle Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.90 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jan 2021 | Bank Of India | ₹0.90 M | Open |
How Many Employees Work at Myrtle Pharmaceutical?
Unlock and access historical data on people associated with Myrtle Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Myrtle Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Myrtle Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.